Tag: baxter
-
Baxter Recalls Sodium Chloride Injection Over Fiberglass Contamination
Baxter has issued a recall for two lots of 0.9% Sodium Chloride Injection due to potential fiberglass contamination. This poses serious health risks, including blood clots and organ damage, prompting immediate discontinuation of use.
HealthBusinessMedical ScienceEducationSocial Issues Product RecallBaxterSodium Chloride InjectionFiberglassFDAPatient SafetyPharmaceuticalsFood RecallsDrugs
-
Baxter Recalls Anticoagulant Solution Over Fiberglass Contamination Risk
Baxter has issued a nationwide recall for one lot of Anticoagulant Sodium Citrate Solution due to potential fiberglass particulate matter. The solution, used with apheresis devices, poses risks of irritation, inflammation, and systemic embolization.
HealthBusinessMedical ScienceFederal GovernmentLegal BaxterAnticoagulant Sodium Citrate SolutionProduct RecallFiberglassApheresisFDAPublic SafetyFood RecallsDrugs
-
Baxter Recalls 70% Dextrose Injection Over Stainless Steel Particles
Baxter is recalling one lot of 70% Dextrose Injection due to stainless steel particles. The contaminated product, distributed in AL, GA, TN, poses risks like blood clots and organ damage. Consumers should discontinue use and return affected units.
HealthBusinessScience & TechnologyMedical ScienceLegalEducationSocial Issues Baxter70% Dextrose InjectionProduct RecallParticulate MatterParenteral NutritionFDA MedWatchHealthcareFood RecallsFDADrugs
-
Baxter Recalls Cefazolin in Dextrose Injection Due to Cardboard Particulates
Baxter is recalling a lot of Cefazolin in Dextrose Injection due to cardboard particulate matter found in the solution, posing risks like pulmonary emboli and organ damage.
HealthBusinessMedical ScienceFederal GovernmentLegal BaxterCefazolinProduct RecallParticulate MatterDextrose InjectionUS Food and Drug AdministrationPulmonary EmboliFood RecallsFDADrugs
-
FDA Issues Early Alert on Baxter Duo-Vent Solution Sets Over Air Bubble Risk
The FDA has issued an Early Alert for Baxter Duo-Vent solution sets, which may introduce air bubbles into IV lines, posing serious risks like stroke or death for vulnerable patients. Baxter recommends removal of affected lots.
HealthBusinessPolitics and GovernmentMedical ScienceFederal GovernmentSocial Issues BaxterDuo-Vent solution setsAir bubblesMedical devicesFDAProduct RecallPatient safetyFood RecallsDrugs
-
FDA Issues Early Alert for Baxter Volara System Circuits Due to Leakage Risk
The FDA has issued an Early Alert regarding Baxter's Volara System single-patient use circuits, which may leak air and medication. This issue can lead to ineffective therapy and patient desaturation.
HealthBusinessScience & TechnologyMedical ScienceLegalSocial Issues BaxterVolara SystemFDAMedical Device CorrectionAir LeakagePatient SafetyMedical DevicesFood RecallsDrugs